Vaxcyte, Inc.
Cash Flow Statement
| Line Item | Jun 2020 | Mar 2020 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-20.3M | $-27.1M |
| Depreciation & Amortization | $400.0K | $384.0K |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $1.3M | $372.0K |
| Net Cash from Operating Activities | $-9.2M | $-13.6M |
| Investing Activities | ||
| Capital Expenditures | $55.0K | $349.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-55.0K | $-349.0K |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $264.5M | $109.8M |
| Net Change in Cash | $255.3M | $95.8M |
| Free Cash Flow | $-9.2M | $-14.0M |